Epsilon Mol.Co

1 known investors

Epsilon Molecular Engineering develops and screens functional VHH (single-domain) antibodies using its cDNA display technology and proprietary PharmaLogical humanized antibody library, offering animal-free antibody discovery. It supports pharmaceutical and diagnostics companies with drug discovery, diagnostic reagent development, and next-generation cell manufacturing solutions.